Investment
Features
FeesSafety
Academy
More
Pluang+

deSPXA token now accepted as collateral on Hyperdrive for USDC loans on Base network

Protocol Fundamentals
07 Oct 2026
Crypto Briefing
View Source
Bullish
deSPXA token now accepted as collateral on Hyperdrive for USDC loans on Base network

Centrifuge’s deSPXA token, representing exposure to the S&P 500 index fund, is now accepted as collateral on Hyperdrive, a lending platform on the Base Ethereum layer-2 network. Eligible non-US users can deposit deSPXA and borrow USDC at borrowing costs below 1% APR as of October 2026. Hyperdrive uses a pricing model tied to the net asset value of the underlying fund to reduce liquidation risk. While the current market size is modest with around $15.9K locked, incentives like a 50K USDC lender reward aim to grow supply and meet borrower demand, marking a step forward for tokenized equities in decentralized finance.

Centrifuge's deSPXA token, now accepted as collateral on Hyperdrive, is part of a broader cryptocurrency market where only 5 of 50 major cryptocurrencies rose today. For readers following digital assets, here is Pluang's market snapshot as of Oct 07, 2026 21:23 WIB: The Graph (GRT) fell 8.70% to Rp479 with a typical hold time of 98 days and 74% sell orders, Filecoin (FIL) dropped 8.63% to Rp18,987 with 56% sell orders, while The Sandbox (SAND) gained 8.33% to Rp1,278 with 63% sell orders.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
58 minutes ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
1 hour ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App